Low Vitamin D Levels Linked to Higher Acute Coronary Syndrome Risk

Adults with serum 25-hydroxyvitamin D concentrations below 30 ng/mL face significantly higher odds of acute coronary syndrome, according to a case-control study conducted at an Indian tertiary care center.

The relationship between circulating micronutrient levels and major cardiac events has long engaged clinical researchers seeking sharper tools for risk stratification. While conventional factors like hypertension and diabetes dominate cardiovascular assessments, investigators continue to explore novel biomarkers that might illuminate underlying disease mechanisms. Recent clinical data from medical wards and intensive care units provide a clearer look at how widespread vitamin D shortfalls intersect with acute vascular events, reinforcing the clinical relevance of routine nutritional screening.

Case-Control Findings From the Nagpur Medical Wards

A hospital-based case-control study conducted over a two-year span evaluated 140 participants at the NKP Salve Institute of Medical Sciences and Research Center and Lata Mangeshkar Hospital in Nagpur, India. The investigation matched 70 patients experiencing acute coronary syndrome—including ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, and unstable angina—with 70 healthy controls by age and sex.

Using a chemiluminescent immunoassay to measure serum 25-hydroxyvitamin D concentrations, researchers categorized participant status into severe deficiency below 10 ng/mL, mild-to-moderate deficiency between 10.0 and 19.9 ng/mL, insufficiency from 20.0 to 29.9 ng/mL, and sufficiency at 30 ng/mL or higher. The data revealed that both deficiency and insufficiency occurred with markedly higher frequency among the patient cohort than among the control group.

Multivariable logistic regression analysis, adjusted for age and sex, established that participants with serum concentrations below 30 ng/mL carried an adjusted odds ratio of 3.28 for acute coronary syndrome compared to those with sufficient levels. Although severe and milder deficiencies were both more prevalent among cases, the study found no statistically significant link between serum vitamin D status and the angiographic extent of coronary artery disease.

Cellular Mechanisms and Population Prevalence

The biological plausibility connecting vitamin D status to cardiovascular health stems from its wide-ranging systemic roles. Synthesized primarily in the skin through sunlight exposure and hydroxylated first in the liver into 25-hydroxyvitamin D, the compound binds to receptors situated directly on vascular endothelial cells, vascular smooth muscle cells, and cardiomyocytes. These receptors help regulate vascular integrity, inflammatory responses, and the renin-angiotensin-aldosterone system.

Laboratory models indicate that optimal active vitamin D acts as an inhibitor of myocardial cell hypertrophy and helps suppress pro-inflammatory pathways. When levels drop, vascular tissue often exhibits impaired endothelial function, increased arterial stiffness, and heightened prothrombotic activity. Immune regulation is similarly affected, as sufficient vitamin D helps inhibit pro-inflammatory cytokines such as interleukin-6 and tumor necrosis factor-alpha while promoting anti-inflammatory mediators like interleukin-10.

Despite abundant regional sunshine, vitamin D deficiency affects roughly 50% to 90% of the Indian population across diverse age groups and geographies. This widespread shortfall has focused scientific attention on its potential contribution to the expanding burden of cardiovascular disease.

Broad Population Data From NHANES Surveys

Parallel insights into vascular health emerge from broader epidemiological evaluations in the United States. Analyses of nationally representative cohorts through the National Health and Nutrition Examination Survey have long examined the correlates of vitamin D status among adults aged 40 and older. These large-scale surveys incorporate standardized physical examinations, blood pressure measurements via American Heart Association protocols, and laboratory assays administered at mobile examination centers.

In standardizing these population assessments, researchers track concurrent factors such as body mass index, smoking history—incorporating screening questions like Do you smoke cigarettes now?—and physician-diagnosed diabetes mellitus. Such comprehensive variables allow epidemiologists to isolate nutritional markers from traditional cardiovascular confounders.

While case-control findings point to strong statistical associations between depressed vitamin D levels and acute cardiac events, investigators emphasize that retrospective designs cannot establish causality or temporal sequence. Researchers agree that larger prospective studies remain essential to determine whether targeted vitamin D repletion can independently improve long-term cardiovascular outcomes.